Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian S. Blagg
CDC37 as a Novel Target for the Treatment of NPM1-ALK Expressing Anaplastic Large Cell Lymphomas
Blood Cancer Journal
Oncology
Hematology
Related publications
ALK-negative Anaplastic Large Cell Lymphoma
Reactive Oxygen Species and Lipoxygenases Regulate the Oncogenicity of NPM-ALK-positive Anaplastic Large Cell Lymphomas
Oncogene
Cancer Research
Genetics
Molecular Biology
Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Alk Expression Plays Different Roles in Anaplastic Large-Cell Lymphomas and Outcome of Crizotinib Use in Relapsed/Refractory Alk+ Patients in a Chinese Population
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Secondary CNS Involvement of ALK-negative Anaplastic Large Cell Lymphoma
American Journal of Hematology
Hematology
Prognostic Significance of NPM-ALK Fusion Transcript Overexpression in ALK-positive Anaplastic Large-Cell Lymphoma
Modern Pathology
Forensic Medicine
Pathology
Intravascular ALK-Positive Anaplastic Large-Cell Lymphoma Mimicking Inflammatory Breast Carcinoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Constitutive Control of AKT1 Gene Expression by JUNB/CJUN in ALK+ Anaplastic Large-Cell Lymphoma: A Novel Crosstalk Mechanism
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Breast Implant‐associated Anaplastic Large Cell Lymphoma and Other Rare T‐cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
